Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
|Slideshows|October 28, 2019
Statements from organizations regarding breastfeeding and substance use
These four statements can help provide ob/gyns with guidance about how to counsel patients with substance use disorder about breastfeeding.
Advertisement
Advertisement
Related to this article
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
SUID was the largest single contributor to the Black-White infant mortality gap in 2024 and drove the biggest share of its rise since 2020.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG guideline expands menopause VMS, sleep, and mood recommendations
2
Countering COVID-19 vaccine myths in pregnancy
3
Organon reports interim phase 3 data for MIUDELLA IUD through 6 years
4
What ACOG's 2026-27 respiratory virus guidance means in practice
5